Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zoetis Inc (NYSE:ZTS)

70.79
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
48.55
Today|||52-Week Range
71.12
+32.24%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$34.5B

Company Description

Zoetis, Inc. discovers, develops and manufactures a portfolio of animal health medicines and vaccines, complemented by diagnostic products, genetic tests, bio devices and services, which are designed to meet the needs of veterinarians and the livestock farmers and companion animal. The company was founded in July 2012 and is headquartered in New York, NY.

Contact Information

Zoetis, Inc.
10 Sylvan Way
New Jersey New Jersey 07054
P:(973) 822-7000
Investor Relations:

Employees

Shareholders

Other institutional48.86%
Mutual fund holders46.39%
Individual stakeholders26.13%

Top Executives

Juan Ramón AlaixPresident, Chief Executive Officer & Director
Kristin C. PeckExecutive Vice President & President-US Operations
Glenn DavidChief Financial Officer & Executive Vice President
Catherine Ann KnuppExecutive VP, President-Research & Development
Andrew FentonChief Information Officer & Executive VP